BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The awarding of lots is not appropriate for this procurement.
Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| GlaxoSmithKline UK Ltd - Vaccines | - | ~£1 estimated from lot values | - |
| Merck Sharpe & Dohme (UK) Limited | - | ~£1 estimated from lot values | - |